Increased NHE1 expression is targeted by specific inhibitor cariporide to sensitize resistant breast cancer cells to doxorubicin in vitro and in vivo
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|4 Apr 2018||Submitted||Original manuscript|
|21 May 2018||Author responded||Author comments - Qi Chen|
|Resubmission - Version 2|
|21 May 2018||Submitted||Manuscript version 2|
|14 Sep 2018||Reviewed||Reviewer Report - Nasser Samadi|
|9 Nov 2018||Reviewed||Reviewer Report - Ebrahim Azizi|
|30 Nov 2018||Reviewed||Reviewer Report - Reviewer 2|
|25 Dec 2018||Author responded||Author comments - Qi Chen|
|Resubmission - Version 3|
|25 Dec 2018||Submitted||Manuscript version 3|
|23 Jan 2019||Reviewed||Reviewer Report - Reviewer 2|
|19 Feb 2019||Author responded||Author comments - Qi Chen|
|Resubmission - Version 4|
|19 Feb 2019||Submitted||Manuscript version 4|
|20 Feb 2019||Editorially accepted|
|8 Mar 2019||Article published||10.1186/s12885-019-5397-7|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.